| Pharmaceutical Information |
| Drug Name |
Ospemifene |
| Drug ID |
BADD_D01630 |
| Description |
Ospemifene is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. FDA approved on February 26, 2013. |
| Indications and Usage |
Ospemifene is used for the treatment of moderate to dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. |
| Marketing Status |
approved; investigational |
| ATC Code |
G03XC05 |
| DrugBank ID |
DB04938
|
| KEGG ID |
D08958
|
| MeSH ID |
C119141
|
| PubChem ID |
3036505
|
| TTD Drug ID |
D02CTS
|
| NDC Product Code |
69037-0026; 55494-580; 63069-601; 59630-580; 50056-2021; 66039-912 |
| UNII |
B0P231ILBK
|
| Synonyms |
Ospemifene | Z-2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol | Osphena | Senshio | FC-1271a |
|
| Chemical Information |
| Molecular Formula |
C24H23ClO2 |
| CAS Registry Number |
128607-22-7 |
| SMILES |
C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
